$UFOTRTH This rebalance trims Palantir and Lockheed Martin back under our 14% single position limit after both grew past it on price, and moves the proceeds into Rocket Lab and Planet Labs to rebuild our space holdings after a hard two weeks. SpaceX's spectrum purchase and its new approval to connect directly to phones pulled the whole space group lower, and Rocket Lab moved the first Neutron flight into 2027 after finding a defect in a tank dome. Rocket Lab had flagged that risk in August, and the stock now trades near half the average analyst target. September inflation came in at 3.7%, which raised the odds of another Fed hike on October 28. NASA says it has released all of its records under PURSUE, and the Department of War opened a case on an Apollo 17 photograph. Northrop, Lockheed and Booz Allen report earnings next week. PLTR 14.92% to 13.50% LMT 14.38% to 13.30% RKLB 7.87% to 9.12% PL 2.49% to 3.54% All other positions unchanged.
This rebalance trims Palantir from 15.16% to 13.50% and returns our managed futures hedge from 18.54% to the 17.50% we set in August, moving the proceeds into Lockheed Martin and Northrop Grumman. Palantir grew past our 14% single position limit on price, and our defense holdings slipped below the 25% minimum we keep in the prime contractors. This trade restores both limits with room on each side, and the hedge sale locks in the gains it earned during September's bond selloff. September moved the disclosure process forward. On September 14, the Department of War authorized current and former personnel and contractors holding UAP related defense information to share it directly with the PURSUE office, setting aside nondisclosure enforcement for those conversations, and on September 18 it published its 6th release of UAP files, including the full AAWSAP contract record! Lockheed and Northrop sit squarely in the contractor base that channel reaches. The Fed raised rates on September 16, the 10 year Treasury yield reached its highest level since 2007, and Congress funded the government through December 11, which moves the full year defense budget past the midterms. PLTR 15.16% to 13.50% DBMF 18.54% to 17.50% LMT 12.15% to 13.30% NOC 10.97% to 12.52% All other positions unchanged.
$UFOTRTH This rebalance trims Palantir back to our 14% single position limit and moves that capital into Lockheed Martin and Northrop Grumman. Palantir has been our strongest performer and grew into 15.84% of the book on price alone. We haven't bought a share since July. The limit exists so no single name decides the fund’s outcome, and we're enforcing it rather than moving it. This is a position size decision, not a call on the business. Defense had drifted below our floor as the primes lagged a market rewarding high growth all month. Lockheed goes to 13.05% and Northrop to 11.66%, both prime contractors with classified program access, both at discounts to their highs, both far less volatile than what we sold. The space sleeve holds. Rocket Lab, Intuitive Machines, Planet Labs and AST SpaceMobile fell last week on rising yields and rotation out of capital intensive growth, not on anything company specific, and they fell the same week the President signed a memorandum directing more than 1,000 domestic launches and reentries annually by 2030, up from 178 last year. The price move and the policy are pointing in opposite directions and we’re not selling anything into that ambiguity.
This rebalance rebuilds the space sleeve from 15.62% to 21.00% and flattens the top of the book. Rocket Lab moves from 6.61% to 10.00%. Planet Labs, Intuitive Machines and AST SpaceMobile each move up modestly. Rocket Lab confirmed a $266 million Department of Defense award in July and now trades roughly 55% below its high after a sector wide selloff in small cap space driven by financing supply rather than by any change in the underlying businesses. We are buying that discount. Funding comes from Booz Allen and Lockheed Martin, with smaller trims to Palantir and Nvidia. Booz Allen reported a large earnings beat this morning with operating margin up to 10% and free cash flow margin near triple last year. We are trimming it on position size, not on the business. Lockheed had grown into an outsized share of the book. Northrop moves up to 11.50% to keep prime defense exposure steady. DBMF rises to 19.00% and remains our downside anchor into the July FOMC meeting.
$UFOTRTH Rocket Lab just agreed to acquire Iridium in an $8 billion deal at $54 a share, and this fund owned Iridium going in. That is the disclosure thesis working exactly as designed. Small space names are live takeout targets, and we were positioned in one of them before the bid landed. The fund is recovering strongly from the sector wide selloff that followed the SpaceX IPO. Over the past week we are up 5.90% against a market up 2.07%, and we stand at +57.34% all time against a market up 26.93%. The June drawdown was concentrated in small space names moving together, not broad market risk, and that sleeve is now bouncing back. This rebalance locks the Iridium win and repositions for the summer. We exit Iridium at the deal price. There is no upside left above the fixed offer, and holding to close in 2027 would convert the stake into Rocket Lab shares and raise our risk, so we take the gain and redeploy. We also exit Mercury Systems. Proceeds concentrate our highest conviction frame agnostic core. Booz Allen, Lockheed Martin, Palantir, and Northrop Grumman all step up. We hold Rocket Lab, whose profile just strengthened with the Iridium acquisition, alongside Nvidia. We add to our managed futures ballast to steady the book, and we trim but keep our space tail, because that tail is exactly where the next takeout can come from.
$UFOTRTH Trimmed down to 12 names today, right before a heavy stretch. CPI Wednesday, the SpaceX IPO Thursday, the Fed next week. Cleaned house. Sold three redundant ETFs, because paying for overlap and getting nothing back is too much like pissing into the wind. Also cut the gold. I know it’s a soft metal, but I didn’t realize how nutless and frail it had gotten. Quit acting like a hedge weeks ago and started trading like a rate bet, so it’s a hard swipe left, right next to unibrows, sea donkeys, and undercooked street meat. Added back where I actually have conviction. Planet Labs put up record revenue last night, defense and intel up 65%, and the stock sold off anyway on margins, so I bought the dip. Chicks will dig it! Leaned harder into Northrop, Lockheed, and Booz Allen for the classified side of the disclosure antics. Just wait till one of these guys drops reverse engineered tech onto the balance sheet… gasp. And I put on a managed futures position to do gold’s old job, which is to actually make money when the market rolls over. When you’re as flaccid as gold has been, it’s hard to stay up without a fluffer. There's no time for that nonsense. Every name left is big enough to move the needle, and the whole thing moves around less than it did. This is the beta and the book I want going into the next two weeks. LFG!!
Changes: Sell IRDM, Sell NVDA, Buy GLD, Buy BAH, Buy MRCY $UFOTRTH With three macro catalysts stacked in a 21 day window (May CPI June 10, SpaceX IPO June 12, FOMC dot plot June 17), we are executing a tactical hedge rebalance to lock select gains, expand our gold hedge while volatility is compressed, and improve frame agnostic positioning. The fund printed +7.93% over the past week against a market up 2.39%, with the past month at +17.57% versus market +4.83%. All-time return now sits at +92.85%. This rotation moves 3.20% of book. Moves. IRDM trims from 11.76% to 9.50%, locking the gain accumulated since the Aireon acquisition drove the stock to a multi-month high at extreme premium to fair value. NVDA reduces from 8.94% to 8.00% to take beta down ahead of the Fed dot plot. GLD expands from 6.39% to 8.00% as our chaos hedge, sized while volatility remains compressed and gold has pulled back into an attractive entry. BAH increases to 9.00% as our highest conviction position across both possible disclosure outcomes, scoring at the top of our framework whether disclosure resolves toward conventional non-human intelligence contact or toward something more paradigm-altering. MRCY adds 3 basis points for advanced sensor mission computing exposure. Beta drops from approximately 1.40 to 1.30. Highlights. RKLB held at 11.62% under a raised 12% soft cap given accelerating fundamentals including the $2.2 billion backlog, $190 million DoD hypersonic contract, and $90 million Space Force GEO award. We do not trim a winner whose thesis keeps reinforcing itself. Locks IRDM strength after a sharp run on the Aireon catalyst. Gold hedge expansion is being added at a relative discount to last week. Lowlights. Trimming IRDM gives up upside if the SpaceX IPO halo extends to satellite communications. Holding NVDA at 8.00% reduces participation if AI capex acceleration continues through Q2. We accept these tradeoffs to position across the CPI and FOMC tape risk in the coming 21 days. The 60 day window remains catalyst dense. Disclosure framing continues to bifurcate. Some signals point toward conventional contact disclosure consistent with what most investors anticipate from AARO and Pentagon channels. Other signals from members of Congress increasingly reference interdimensional, consciousness-based, and biblical framings that would represent a fundamentally different paradigm. The fund is positioned to capture upside in either scenario rather than betting on one. PURSUE rolling UAP disclosure releases continue under the Trump declassification directive, the AARO 2025 annual report remains pending, SpaceX IPO June 12, two macro prints, Fed dot plot. The fund was built for this environment.
$UFOTRTH Following Rocket Lab’s Q1 earnings beat that drove RKLB up 30% intraday, we are executing a frame agnostic rebalance to lock in earnings strength, reduce concentration, and reposition for the disclosure catalyst window. The fund sits at +62.62% all time against a market up 23.33%. RKLB expanded to 16.19% of book, well above our 14% cap. This rebalance trims RKLB to 9.00%, liquidates LIT, and reduces NUKZ to 4.00% to fund five moves. BAH triples to 8.00% as our highest conviction frame agnostic position. NOC enters at 2.50% for classified space. MRCY enters at 2.50% for advanced sensor mission computing. PLTR increases to 10.50% on universal data fusion. GLD increases to 7.69% to expand chaos hedge. Dollar neutral at 14.45% rotation. Beta drops from 1.40 to approximately 1.25. Highlights. Locks in RKLB strength near $102. Liquidates LIT. Triples BAH, the only position scoring top five on both neighborly and ontological frameworks. Top four positions now within 1.22 percentage points, eliminating single name dominance. Lowlights. Selling RKLB into strength gives up upside if the rally extends. IRDM held at 10.64% despite Q1 weakness for SpaceX IPO rotation and Q2 catalysts. We accept these tradeoffs to position across multiple disclosure scenarios. The 60 day window remains the most catalyst rich since inception: Greer today, Trump declassification directive in Pentagon review, AARO’s overdue 2025 report, statutory NORAD UAP briefings, SpaceX IPO target, two FOMC meetings, and increasingly interdimensional framing from Burlison, Luna, Burchett, and Mace. The fund was built for this environment.
$UFOTRTH April rebalance. The fund sits at +48.62% all time and +3.48% YTD against an S&P 500 that is down 3.56%. Since the February 25 rebalance we have navigated the US Iran conflict, a defense rally, and a tech correction that pulled NVDA and PLTR 15 to 25% off their highs. Best performers in this window were NUKZ at +60.7% YTD on nuclear renaissance momentum, LMT on Iran war demand, and IRDM on the SpaceX IPO filing and satellite rotation. DJT was the weakest link, drifting toward its 52 week low on a $712M annual loss with zero thesis relevance. This rebalance removes DJT, REMX, and TSLA in full, trims ARKX from 7.78% to 5.50%, and adds 3 new positions. Planet Labs (PL) enters at 4.00% as a high conviction add. PL delivered 4 consecutive EBITDA profitable quarters, grew defense and intelligence revenue over 50%, and its hyperspectral Tanager satellite is directly applicable to the anomaly detection infrastructure AARO needs. Intuitive Machines (LUNR) enters at 2.50% on NASA CLPS pipeline momentum, the $180.4M contract win, and Artemis II tailwinds. Booz Allen Hamilton (BAH) enters at 2.24% as the defense consulting firm most deeply embedded in classified programs, with quantum sensing, AI cyber, and multi modal ISR capabilities, trading at a P/E of 12.44 with a 2.7% dividend yield. The trade is dollar neutral at $961.40 each side. Post rebalance beta drops modestly from 1.4 to approximately 1.35. The 60 day window ahead is the most catalyst rich since inception. Rep. Luna formally demanded UAP footage from the Pentagon on April 1. Alien.gov and aliens.gov were registered by CISA on March 17 and remain pending launch. AARO’s 2025 Annual Report is overdue. The NDAA’s statutory NORAD NORTHCOM UAP intercept briefings carry a spring 2026 deadline. Trump’s February 20 declassification directive is in active Pentagon compliance review. Earnings from LMT, IRDM, TSLA, KTOS, LUNR, and NVDA all land inside the window, as do 2 FOMC meetings, the SpaceX IPO target, and the April 10 CPI print. This is the environment the fund was built for.
Following President Trump’s executive order to declassify UFO and UAP related government files, we are repositioning the portfolio to capture maximum upside from the anticipated disclosure event. This rebalance increases our core space and classified aerospace exposure from 21% to 45%, exiting non-thematic technology positions (CIBR, BOTZ) and trimming commodity exposure to redeploy into high-conviction disclosure plays. We are adding AST SpaceMobile for satellite communications infrastructure, significantly increasing ARKX for diversified space sector exposure, and boosting ITA to reduce single name defense concentration. RKLB remains our anchor position at 12%, sized for the launch capacity bottleneck that disclosure era space commercialization will create, while LMT’s Skunk Works and classified programs position us for potential reverse engineered technology revelations. Materials exposure has been focused exclusively on uranium (nuclear propulsion) while exiting rare earths and reducing lithium to eliminate commodity drag. This is an aggressive, event driven allocation acknowledging that markets price catalysts on anticipation, not announcement, we are positioning now while institutional investors are still building exposure, accepting higher volatility for asymmetric upside if disclosure materializes as expected in the coming 30-60 days.